Profil
Hubert de Ruty is associated with Sanofi Srl and Sanofi Développement Pharma SASU.
He is currently the Chairman & Chief Executive Officer of Sanofi Srl and Chairman of Sanofi Développement Pharma SASU.
Postes actifs de Hubert de Ruty
| Sociétés | Poste | Début |
|---|---|---|
Sanofi Srl
 Sanofi Srl Pharmaceuticals: MajorHealth Technology Sanofi SpA engages in the research, production, and distribution of pharmaceuticals. It provides solutions for the treatment of diseases in various medical fields such as cardiovascular, diabetes, oncology and blood cancers, nephrology, equivalent medicines, rare diseases, and multiple sclerosis as well as develops vaccines. The company was founded in 1973 and is headquartered in Milan, Italy. | Directeur Général | 14/02/2018 |
Sanofi Développement Pharma SASU
 Sanofi Développement Pharma SASU Financial ConglomeratesFinance Part of Sanofi, the company is a pharmaceutical holding company based in Paris, France. According to the French company metadata, Sanofi Développement Pharma SASU functions as a holding company. The company was founded in 1995 and Mathias Thibault has been the CEO of the company since 2020. | Président | 11/07/2020 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Sanofi Srl
Sanofi Srl Pharmaceuticals: MajorHealth Technology Sanofi SpA engages in the research, production, and distribution of pharmaceuticals. It provides solutions for the treatment of diseases in various medical fields such as cardiovascular, diabetes, oncology and blood cancers, nephrology, equivalent medicines, rare diseases, and multiple sclerosis as well as develops vaccines. The company was founded in 1973 and is headquartered in Milan, Italy. | Health Technology |
Sanofi Développement Pharma SASU
Sanofi Développement Pharma SASU Financial ConglomeratesFinance Part of Sanofi, the company is a pharmaceutical holding company based in Paris, France. According to the French company metadata, Sanofi Développement Pharma SASU functions as a holding company. The company was founded in 1995 and Mathias Thibault has been the CEO of the company since 2020. | Finance |
